Fumito Wada
Impact in
-
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- CRISPR and Genetic Engineering
- RNA modifications and cancer
-
- MicroRNA in disease regulation
Papers in
-
- Advanced biosensing and bioanalysis techniques 17
- DNA and Nucleic Acid Chemistry 14
- RNA Interference and Gene Delivery 12
- RNA and protein synthesis mechanisms 2
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- CRISPR and Genetic Engineering 2
- Co-authors
- Tsuyoshi Yamamoto (18 shared papers)Satoshi Obika (18 shared papers)Mariko Harada‐Shiba (15 shared papers)Hidenori Yasuhara (5 shared papers)Shinichiro Hori (2 shared papers)Asako Yamayoshi (4 shared papers)Yoshiyuki Hari (3 shared papers)Kenji Nakano (1 shared paper)
- Journals
- Nucleic Acid Therapeutics (3 papers)Organic & Biomolecular Chemistry (3 papers)Molecular Therapy — Nucleic Acids (2 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)Pharmaceutics (1 paper)
- Partner nations
- JapanCzechiaUnited States
In The Last Decade
Fumito Wada
21 papers receiving 318 citations
Peers
Comparison fields: 5 of 50
- Molecular Biology 293
- Cancer Research 31
- Sensory Systems 5
- Biotechnology 8
- Oncology 19
Countries citing papers authored by Fumito Wada
This map shows the geographic impact of Fumito Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumito Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumito Wada more than expected).
Fields of papers citing papers by Fumito Wada
This network shows the impact of papers produced by Fumito Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumito Wada. The network helps show where Fumito Wada may publish in the future.
Co-authors
The 25 scholars most cited alongside Fumito Wada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 42 | |
| 2 | 2016 | 36 | |
| 3 | 2015 | 34 | |
| 4 | 2015 | 34 | |
| 5 | 2017 | 31 | |
| 6 | 2014 | 17 | |
| 7 | 2018 | 17 | |
| 8 | 2021 | 16 | |
| 9 | 2012 | 15 | |
| 10 | 2016 | 13 | |
| 11 | 2017 | 12 | |
| 12 | 2016 | 11 | |
| 13 | 2013 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2018 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2023 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2020 | 2 |
About Fumito Wada
Fumito Wada is a scholar working on Molecular Biology, Biochemistry, Cancer Research, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 21 papers that have together received 323 indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (17 papers), DNA and Nucleic Acid Chemistry (14 papers), RNA Interference and Gene Delivery (12 papers), MicroRNA in disease regulation (2 papers), RNA and protein synthesis mechanisms (2 papers), RNA modifications and cancer (2 papers), RNA Research and Splicing (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Molecular Biology (293 citations), Cancer Research (31 citations), Sensory Systems (5 citations), Biotechnology (8 citations) and Oncology (19 citations). Fumito Wada has collaborated with scholars based in Japan, Czechia and United States. Frequent co-authors include Tsuyoshi Yamamoto, Satoshi Obika, Mariko Harada‐Shiba, Hidenori Yasuhara, Shinichiro Hori, Asako Yamayoshi, Yoshiyuki Hari, Kenji Nakano, Kiyoko Setoguchi and Lin Cui. Their work appears in journals such as Nucleic Acid Therapeutics, Organic & Biomolecular Chemistry, Molecular Therapy — Nucleic Acids, Bioorganic & Medicinal Chemistry Letters and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.